ClinicalTrials.gov
public full text
Public Domain
An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies
colorectal-cancerdiffuse-large-b-cell-lymphoma-dlbcllymphomanon-small-cell-lung-cancerpancreatic-adenocarcinomasolid-tumor
This was a study of INCB054329 given to patients with advanced malignancies that were conducted in three treatment groups. Each treatment group had a dose escalation (Part 1) and a dose expansion (Part 3), two of the treatment groups also had an intra-patient dose titration (Part 2).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Dose Escalation With Expansion Study of EMB-01 in Participants With Advanced/Metastatic Solid Tumors#1161441
- Safety of AM-928 Infusion in Advanced Solid Tumors#1094619
- Phase I Study in Patients With Solid Tumours#878040
- An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid Tumors#850016
- A Dose Escalation Study of OMP-52M51 in Subjects With Solid Tumors#846356
Record · ID 807660
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive